Skip to content
Search

Latest Stories

Loneliness epidemic: Over half of Europeans ‘often or occasionally’ feel lonely

Loneliness epidemic: Over half of Europeans ‘often or occasionally’ feel lonely

Younger Europeans are more prone to feelings of loneliness, largely due to their extensive screen time

Despite being more connected than ever, the majority of Europeans are experiencing feelings of loneliness. The STADA Health Report 2024, released on Monday, revealed that over half (52 per cent) of Europeans “always, often or occasionally” feel lonely.

Although the younger generation reports the highest levels of overall happiness, they are the ones most affected by this current loneliness epidemic.


Nearly two-thirds (63 per cent) of Europeans aged 18 to 35 reported feeling lonely, compared to 41 percent of those aged 55 and older – according to the report, based on a survey of over 46,000 respondents aged 18 to 99 across 32 countries.

Loneliness epidemic

Extensive screen time is contributing to increased loneliness among younger people. Europeans under the age of 34 are much more likely to spend long hours on their devices (41 per cent) than those aged 35–54 (22 per cent) and those over 55 (13 per cent).

The survey found that people who spend a "long" or "fair" amount of time on social media were significantly more prone to feelings of loneliness compared to those who restrict their screen time. Moreover, extensive screen time was also associated with more intense feelings of loneliness.

However, many young Europeans remain unaware of this correlation, as only 20 per cent of younger respondents attributed their feelings of loneliness to spending extensive time on social media or playing computer games. They ranked work as the primary cause of loneliness, followed by remote working, childcare duties, loss of loved ones, or relocating for career reasons.

Throughout Europe, work, lack of free time (23 per cent), loss of partners, family members, or friends (17 per cent), and poor health or mobility issues (14 per cent) were commonly cited as primary causes of loneliness. Women (57 per cent) reported feeling significantly lonelier than men (46 per cent) and were twice as likely to attribute childcare duties (16 per cent) as a reason for feeling lonely compared to their male counterparts (8 per cent).

Loneliness epidemic 2

Loneliness and its consequences

The report warned that loneliness can have serious long-term implications. “Aside from the more obvious consequences like depression and anxiety, it also increases the risk of strokes, heart disease, type 2 diabetes, addiction and dementia,” it stated.

In 2023, the WHO declared loneliness a “global public health concern”, comparing its potential health impacts to heavy smoking and emphasizing that “social isolation knows no age or boundaries”.

To address the loneliness epidemic, nearly half of Europeans surveyed (46 per cent) advocated for improved work-life balance, while 43 percent expressed the need for better economic conditions.

Other proposed solutions include enhancing the availability and accessibility of leisure activities, reducing time spent online, more targeted support for the elderly population, and improved access to therapy.

Loneliness epidemic 3

Europe’s mental health remains stable

On a positive note, the STADA Health Report 2024 indicated that Europeans' mental health has remained relatively stable compared to previous years’ data.

Today, 65 per cent of Europeans rate their mental well-being as 'good' or 'very good.' Men (69 per cent) rate their mental health significantly more positively than women (61 per cent). Last year, sound mental health ratings stood at 67 per cent, an increase of 10 percentage points from 2022.

Two-thirds (67 per cent) of Europeans surveyed described themselves as "quite" or "very happy," while another 26 per cent identified as "neither happy nor unhappy." Only 7 per cent reported being (very) unhappy, which, on the surface, doesn't seem too concerning, as per the report.

However, contrary to expectations that Scandinavian countries might rank highest in happiness, as suggested by the World Happiness Report 2024, the STADA Health Report has revealed a different trend.

While people in Finland (65 per cent), Denmark (67 per cent), and Sweden (63 per cent) reported average or even slightly below-average individual happiness levels, they are surpassed by countries like Uzbekistan (87 per cent), the Netherlands (80 per cent), Ireland (77 per cent), France (74 per cent), and both the UK and Switzerland (73 per cent each).

A common trend seen across European countries is that, generally, happiness decreases with age. Among Europeans aged 18 to 34, 72 per cent describe themselves as "quite" or "very happy," compared to 67 per cent of middle-aged Europeans and 65 per cent of those over 55.

The link between physical and mental health

On average, 54 per cent of Europeans rate their physical health as "good" or "very good". The report highlighted a link between physical and mental health, with 70 per cent of Europeans who rate their mental health as good also reporting good physical health. However, this correlation drops to just 17 percent among those who rate their mental health as poor.

The STADA Health Report 2024 also highlighted an increasing level of dissatisfaction among Europeans regarding their national healthcare systems.

Only 56 per cent of respondents indicated satisfaction with their country's healthcare system, marking the lowest figure in five years. In 2020, this satisfaction rate stood at 74 per cent, and the number has been declining steadily since then.

 

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less